Eliana Pires Barrenho

Eliana Pires Barrenho

Nationality: Portuguese

Previous education: MSc Health Economics from the University of York, Postgraduate Certificate Entrepreneurship INDEG Business School, BA Economics Universidade Nova Lisboa

Academic background before joining Imperial College Business School

During my undergraduate studies at Universidade Nova de Lisboa, I developed a solid interest in economics. I was particularly intrigued by the incredible opportunities that econometric techniques provide for understanding the reality around us. After earning my first degree, I worked in management consultancy, and after that I moved to Mozambique to lecture for two years.I came to the UK to attend University of York where I graduated with a Master of Science in Health Economics. During my Master’s at University of York I worked on a research project at the Centre for Health Economics (CHE), a research centre affiliated with the university. I graduated with a Master’s thesis in policy evaluation techniques. After earning my masters, I joined the Business School at Imperial to participate in an ESRC (Economic and Social Research Council) project, and enrolled in the PhD programme.
Choosing the PhD Programme at Imperial College Business School

There were three elements that attracted me to the doctoral programme at Imperial College Business School: the prestige and cultural richness of the Imperial College community, the interdisciplinary environment, and the prestigious professors who I have been amazed by working with. Studying the Doctoral programme places you in the best possible position to take advantage of what the intellectual community at Imperial offers, such as attending seminars in Business and Economics or learning from doctors and surgeons at St. Mary’s Hospital.
Research Interests

My research interests are broadly focused on health economics and health policy. Motivated by my interest in both of these fields, I am currently working on my PhD project which examines failure in the innovation process in the biopharmaceutical industry. On the one hand, this analysis aims to provide evidence on how heterogeneous the innovation process is, using sophisticated econometric and statistical tools. On the other hand, we aim to provide some policy recommendation on how to improve the incentives’ design to boost drug innovation, especially in neglected disease areas.
The Imperial Experience

The thing that has impressed me most here is the quality and diversity of my colleagues and members of the faculty. Each student on the programme has a very unique background in terms of previous academic and work experience, as well as different research interests.In addition, there is no way to emphasize enough the phenomenal resources we have here. The gym is fantastic, the campus is unbelievably well located and you are encouraged and supported to participate in symposiums and international conferences.